for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

JP Business

BVTV: Alzheimer’s drug

Biogen’s market value rose $11 bln on news its new treatment for the disease appeared effective. Robert Cyran explains why this rise is rather cautious, and how the drug might exceed Wall Street’s assumptions.

JP Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up